Search for Clinical Trial Results

Sponsored By

Liver Cirrhosis, Biliary - 25 Studies Found

Status Study
Completed Study Name: Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)
Condition: Liver Cirrhosis, Biliary
Date: 2007-10-27
Interventions:
  • Drug: INT-747 Once a day (QD)

Completed Study Name: Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis
Condition: Liver Cirrhosis, Biliary
Date: 2000-02-24
Interventions:
  • Drug: colchicine
  • Drug: methotrexate
Recruiting Study Name: Phase 3 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cirrhosis
Condition: Liver Cirrhosis, Biliary
Date: 2014-11-10
Interventions:
  • Drug: Obeticholic Acid (OCA)

Terminated Study Name: SAMe to Treat Biliary Cirrhosis Symptoms
Condition: Liver Cirrhosis, Biliary
Date: 2005-07-29
Interventions: Drug: S-adenosyl-methionine (SAMe) capsules
Completed Study Name: Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis
Condition: Liver Cirrhosis, Biliary
Date: 2006-11-29
Interventions: Drug: tigecycline Single intravenous dose of tigecycline 50 mg, as a 30-minute infusion
Completed Study Name: Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)
Condition:
  • Liver Cirrhosis, Biliary
  • Biliary Cirrhosi
    Date: 2005-09-02
Completed Study Name: Pentoxifylline for Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Date: 2010-11-24
Interventions: Drug: Pentoxifylline Patients will take 400mg of pentoxifylline three times daily for a total duration o
Completed Study Name: Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis
Condition: Liver Cirrhosis, Biliary
Date: 2000-02-24
Interventions:
  • Drug: methotrexate
  • Drug: ursodiol
Completed Study Name: Initial Study of Rituximab to Treat Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Date: 2006-08-15
Interventions: Drug: rituximab rituximab 1000 mg IV day 1 and 15, given over 5 - 6 hours
Completed Study Name: Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Date: 2011-09-20
Interventions:
  • Biological: Biological: mesenchymal stem cell

Next >>>